Skip to content
Review Open access

Unraveling the pyroptosis-mitophagy axis: from molecular mechanisms to therapeutic opportunities

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 214 references
Medicine

Abstract

Mitophagy and pyroptosis are central regulators of cell fate and inflammation, and they form a complex bidirectional network across many diseases. Mitophagy suppresses NLRP3 inflammasome activation by removing damaged mitochondria and thereby reducing mtROS and mtDNA release, which blocks pyroptosis. Conversely, pyroptosis can inhibit mitophagy by releasing inflammatory mediators and activating caspase-1, creating reinforcing or counterbalancing feedback loops. Signaling modules such as PINK1/Parkin, NOD2-RIPK2, Nrf2/HO-1, and AMPK critically modulate both mitophagy and pyroptosis. These processes interact broadly in organ injuries of the brain, liver, kidney, lung, bone, and heart to determine inflammation intensity and cell survival. Natural small molecules and traditional Chinese medicine that target the mitophagy–pyroptosis axis can modify pathological states including neurodegeneration, metabolic inflammation, and immune evasion, and thus represent a promising strategy for precision therapy.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.